A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2006
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1208214B1 Genetically engineered bleb vaccine
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863817A Antibodies to M-CSF
11/15/2006	CN1863811A Stable vitamin B6 derivative
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863775A Substituted pentanols, a process for their production and their use as anti-inflammatory agents
11/15/2006	CN1863540A Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium
11/15/2006	CN1863507A Remedy or diagnostic for inflammatory disease containing target-directing liposome
11/15/2006	CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof
11/15/2006	CN1861591A Hesperetin derivant and preparation process thereof
11/15/2006	CN1861187A Medicated wine for treating rheumatosis and osteoarthropathy
11/15/2006	CN1861179A Pure traditional Chinese medicine composition and its prepn. method
11/15/2006	CN1861177A Medicinal composition for treating children cold and its prepn. process
11/15/2006	CN1861155A Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby
11/15/2006	CN1861140A Compound Chinese lobelia Tea agent and its prepn. method
11/15/2006	CN1861139A Prepn. method for compound Chinese lobelia liquid prepn. for external use
11/15/2006	CN1861138A Compound Chinese lobelia lozenge and its prepn. method
11/15/2006	CN1861137A Compound semisolid prepn. contg. Chinese lobelia for external use and its prepn. method
11/15/2006	CN1861136A Paederia foetida tea agent and its prepn. method
11/15/2006	CN1861135A External use semi-solid prepn. contg. paederia foetida, and its prepn. method
11/15/2006	CN1861134A Method for preparing injection sterile powder of paederia foetida
11/15/2006	CN1861133A Prepn. method for external use liquid prepn. contg. paederia foetida
11/15/2006	CN1861131A Qingkailing dixinwan pill prepn. and its prepn. method
11/15/2006	CN1861130A Paederia foetida oral solid prepn. and its prepn. method
11/15/2006	CN1861129A Prepn. method for paederia foetida fog-like prepn.
11/15/2006	CN1861128A Paederia foetida oral liquid prepn. and its prepn. method
11/15/2006	CN1861127A Compound lobelia oral liquid prepn. and its prepn. method
11/15/2006	CN1861126A Compound lobelia oral solid prepn. and its prepn. method
11/15/2006	CN1861125A Prepn. method for compound lobelia fog-like prepn.
11/15/2006	CN1861119A Traditional Chinese medicine for treating rheumatosis and its prepn. method
11/15/2006	CN1861074A Application of derivative of hesperetin as anti-inflammatory and immune medicine
11/15/2006	CN1861066A Compounding oral prepn. contg. paracetamol and methionine
11/15/2006	CN1861059A Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method
11/15/2006	CN1861041A Temp-sensitive, slow-releasing gel used for local injection, and its prepn. method
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284773C Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/15/2006	CN1284664C Device for manufacturing dosage forms
11/15/2006	CN1284591C Safflower oil
11/15/2006	CN1284590C Gastrodia tuber contained refractory headache treating formulation and its preparation technique and quality control method
11/15/2006	CN1284568C Chinese medicine preparation for treating coronary heart disease and rheumatic heart disease
11/15/2006	CN1284557C Chinese medicine for removing obstruction in channels and relieving pains and its preparation
11/15/2006	CN1284536C Application of tetrodotoxin or saxitionxin and analogs thereof in preparation of general antalgic medicine application
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135490 Method for the treatment of glomerulonephritis
11/14/2006	US7135489 Cyclooxygenase inhibitors; antiinflammatory agents
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135476 Corticotropin releasing factor antagonists; anxiolytic agents; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,8'-(7H)quinazoline]; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,7'-(5H)cyclopentapyrimidine]
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006	US7135320 Adaptor protein FRS2 and related products and methods
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	CA2379572C Polymorphic salt
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	WO2006119390A1 Pyridines useful as modulators of ion channels
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118196A1 Dpp4 inhibitor and pharmaceutical application thereof
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006117657A1 Triazolone derivatives as anti-inflammatory agents
11/09/2006	WO2006117548A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity
11/09/2006	WO2006117404A2 Topical use of radical capturing substances for antipyretic treatment
11/09/2006	WO2006117316A1 Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
11/09/2006	WO2006117315A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protecctive activity
11/09/2006	WO2006117076A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006069210A3 Oral care compositions containing free-b-ring flavonoids and flavans
11/09/2006	WO2006040181A3 4-phenylsulfonamidopiperidines as calcium channel blockers
11/09/2006	US20060252943 Chemical process
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252833 Improve efficiency when administered with conventional drugs; side effect reduction; Parkinson's disease therapy; administering a fatty acid
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252790 e.g. 5-{5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine; antiinflammatory agent, antiallergen; cognitive impairment; asthma, arthritis
11/09/2006	US20060252784 Imidazo-substituted 1,8-naphthyridinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252783 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006	US20060252681 Pain relief agents
11/09/2006	US20060251751 Sophoridine and its use as an analgesic
11/09/2006	US20060251660 Antibodies to human IL-1beta
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251646 Anti-tirc7 antibodies in therapy of inflammatiory diseases
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	CA2613169A1 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors
11/09/2006	CA2607029A1 A combination of seal oil and cold-pressed virgin olive oil
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor

1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 1272